Orthofix Medical Inc. revised earnings guidance for the year ending December 31, 2023. For the period, the company revised net sales to be in the range of $739 million to $744 million from previous guidance range of $752 million to $758 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14 USD | +1.63% | -3.39% | +3.56% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.56% | 517M | |
-6.22% | 180B | |
-0.22% | 109B | |
-3.39% | 68.93B | |
-4.56% | 46.41B | |
+12.72% | 45.43B | |
+7.38% | 43.26B | |
+19.33% | 30.05B | |
+16.10% | 25.19B | |
-7.35% | 23.34B |
- Stock Market
- Equities
- OFIX Stock
- News Orthofix Medical Inc.
- Orthofix Medical Inc. Revises Earnings Guidance for the Year Ending December 31, 2023